Clinical Trial Technology Editorial
-
Diversity In Clinical Trials: 10 Strategies To Increase Minority Enrollment In Oncology Trials
7/20/2021
Ethnicity, age, and sex can all impact safety and efficacy of any medication in people. Hence, diversity among clinical trial participants is critically important. This article shares 10 interventions to ensure participation of underserved groups to enhance diverse clinical recruitment.
-
eClinical Systems Post-COVID: Have You Realized Your Digital Transformation?
7/13/2021
When the pandemic started to impact our communities, what happened next exemplified the commitment and passion of TMF professionals, clinical researchers, and the pharmaceutical industry as a whole. Now, as the U.S. is in a summer characterized less by COVID and more by time spent with family and friends, are we willing to face COVID’s hard lessons?
-
The Right Payment System Makes Bayer Healthcare A Sponsor of Choice
6/29/2021
Companies hoping to become a sponsor of choice have a lot to consider. They must think about how to improve interactions with patients, sites, CROs, and other service and equipment providers. When Bayer decided to go down the sponsor-of-choice path, there was one aspect of partnering they knew they had to get right: site payments.
-
3 Easy Ways To Implement Tech & Modernize Your Clinical Trial
6/24/2021
The life sciences industry’s digital transformation has provided the tools to overcome many of the industry’s problems and has unlocked new avenues for the role of tech in clinical trials. Going forward, clinical execs can use tech in a multitude of ways to power clinical trials.
-
AstraZeneca Goes All-In On Biomarker Testing & Education
6/17/2021
Recent breakthroughs in precision medicine are revolutionizing cancer care and biomarkers are a key part of the puzzle. Scientific data has been generated that will help researchers understand the biology of cancer and more specifically, tumor profiles at the molecular level. Despite immense scientific advancements in recent years, biomarker testing is not always the standard of care for most people living with cancer. AstraZeneca hopes to change that.
-
Decentralized Trials: Trends & Technology Propelling Home Healthcare Services
6/15/2021
Moving some trial site activities into patients’ homes has been shown to increase recruitment by 60% or more, and it typically maintains patient retention at over 90%. This article delves into research regarding trends and technology enabling decentralized trials.
-
How Clinical Execs Can Embrace Technology (& How To Find Activated Patients Who Do, Too)
5/18/2021
How can we make the clinical trial process more efficient and effective? By embracing technology (for example, AI and machine learning) and finding patients who embrace technology, too. The former deputy chief medical officer for the American Cancer Society shares his thoughts.
-
How Machine Learning Will Eliminate Failures In Clinical Trials
4/28/2021
AI’s full potential will not be realized for at least another decade, but machine learning (a component of AI) is a technology that is available now. Still, judging by the amount of content and webinars I see on this topic, it seems many in the industry are still trying to understand how it will be used and why it may be a game changer when it comes to trial conduct.
-
UCB And Microsoft Collaborate On AI For Therapeutics R&D
4/19/2021
UCB and Microsoft have worked together previously, collaborating on IT solutions in drug discovery and development. Now the two companies have taken that collaboration a step further with an expansion that will allow UCB to better discover and develop medicines for patients living with severe diseases.
-
What Is Driving The Adoption Of EDC Applications?
3/19/2021
In December 2020, Industry Standard Research (ISR) released the 4th edition of its EDC Market Dynamics and Service Provider Performance report. I spoke to Sherry Hubbard-Bednasz, market research director at ISR, for some insights into the report and its findings.